I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Kazuto Nishio, MD, PhD
7
results:
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
Lack of Association of Plasma Levels of Soluble Programmed ..:
Junko Tanizaki, MD, PhD
;
Hiroaki Kuroda, MD, PhD
;
Toshihide Yokoyama, MD
...
http://www.sciencedirect.com/science/article/pii/S2666364323001339. , 2023
Link:
https://doi.org/10.1016/..
?
2
Efficacy of Crizotinib After Entrectinib Resistance Due to ..:
Toshiaki Takakura, MD
;
Hiroaki Kanemura, MD, MPH
;
Kazuko Sakai, PhD
...
http://www.sciencedirect.com/science/article/pii/S2666364323000620. , 2023
Link:
https://doi.org/10.1016/..
?
3
RELAY+: Exploratory Study of Ramucirumab Plus Gefitinib in ..:
Makoto Nishio, MD, PhD
;
Kazuto Nishio, MD, PhD
;
Martin Reck, MD, PhD
...
http://www.sciencedirect.com/science/article/pii/S2666364322000273. , 2022
Link:
https://doi.org/10.1016/..
?
4
The Tumor Immune Microenvironment and Frameshift Neoantigen..:
Hiroaki Kanemura, MD, MPH
;
Hidetoshi Hayashi, MD, PhD
;
Shuta Tomida, PhD
...
http://www.sciencedirect.com/science/article/pii/S2666364322000972. , 2022
Link:
https://doi.org/10.1016/..
?
5
Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in..:
Kazuto Nishio, MD, PhD
;
Takashi Seto, MD
;
Makoto Nishio, MD, PhD
...
http://www.sciencedirect.com/science/article/pii/S2666364321000308. , 2021
Link:
https://doi.org/10.1016/..
?
6
High Incidence of C797S Mutation in Patients With Long Trea..:
Atsushi Osoegawa, MD, PhD
;
Masafumi Yamaguchi, MD, PhD
;
Tomomi Nakamura, MD, PhD
...
http://www.sciencedirect.com/science/article/pii/S2666364321000503. , 2021
Link:
https://doi.org/10.1016/..
?
7
Real-World Evidence of Diagnostic Testing for Driver Oncoge..:
Yasushi Yatabe, MD, PhD
;
Yasumasa Yoshiki, MPH
;
Koichi Matsumura, PhD
...
http://www.sciencedirect.com/science/article/pii/S2666364320301879. , 2021
Link:
https://doi.org/10.1016/..
1-7